Is treating Blood pressure alone enough to protect your
Is treating Blood pressure alone enough to protect your
Is treating Blood pressure alone enough to protect your
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CADUET.. The Dual Efficacy in a Single Pill<br />
AVALON trial, 847 patient with hypertension and dyslipidemia at the end of<br />
week 8. mean dose was 7.6/ 28.4 mg<br />
Mean LDL-C ** reduction<br />
Mean reduction in SBP(mmHg)<br />
Mean reduction in DBP(mmHg)<br />
-12.5<br />
-8.2<br />
-37.2%<br />
- Messerli FH, BaKris GL, et al. Efficacy and Safety of Coadministered Amlodipine and A<strong>to</strong>rvastatin in Patients With Hypertension and Dyslipidemia<br />
Results of the AVALON Trial. Clin Hypertens. 2006;8:571–581<br />
<strong>Is</strong> <strong>treating</strong> <strong>Blood</strong> <strong>pressure</strong> <strong>alone</strong> <strong>enough</strong> <strong>to</strong> <strong>protect</strong> <strong>your</strong><br />
hypertensive patient?<br />
Does the elevation of blood <strong>pressure</strong> increase the atherogenecity<br />
of cholesterol-rich lipoproteins ?<br />
Want <strong>to</strong> go beyond blood <strong>pressure</strong> in patients with hypertension?<br />
EBM.<br />
<strong>Is</strong> it just an antihypertensive treatment + statin?<br />
Who are those hypertensive patients at high CVD risk?<br />
Conclusion.